N/A
N=1,268
Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking
Social Skills · Self-Criticism · Post-traumatic Stress Disorder · Depression · Alcohol Abuse
Bottom Line
View on ClinicalTrials.gov: NCT03488927 ↗Enrolled (actual)
1,268
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Negative Social Reactions — 1.25; 1.28; 1.35 Mean of actual negative reactions scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS) (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of New Hampshire
- Primary completion
- Jun 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Negative Social Reactions |
1.25; 1.28; 1.35 | — |
| SECONDARY Positive Social Reactions |
4.05; 3.87; 3.87 | — |
Summary
The purpose of this randomized controlled trial is to evaluate an intervention, Supporting Survivors and Self: An Intervention for Social Supports of Survivors of Partner Abuse and Sexual Aggression (SSS). SSS trains potential recipients of IPV or SA disclosure on the best methods of responding to a victim's disclosure. Consenting college students will be randomized into the SSS intervention or a wait-list control condition. Evaluation data will be multi-informant (i.e., data from both informal supports and victims) and multi-method (i.e., qualitative and quantitative). The investigators hypothesize that individuals receiving the SSS intervention, compared to individuals in the wait-list control condition, will provide less negative and more positive social reactions to victims' disclosure.
Eligibility Criteria
Inclusion Criteria
- undergraduate student at University of New Hampshire
- read and understand English
- able to independently complete online surveys
Data sourced from ClinicalTrials.gov (NCT03488927). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.